{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T10:13:25Z","timestamp":1780481605579,"version":"3.54.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000191","name":"Kidney Foundation of Canada","doi-asserted-by":"publisher","award":["KHRG-916689"],"award-info":[{"award-number":["KHRG-916689"]}],"id":[{"id":"10.13039\/501100000191","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kireports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International Reports"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ekir.2026.106477","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T23:57:48Z","timestamp":1773273468000},"page":"106477","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Metabolic Dysfunction-Associated Steatotic Liver Disease and Kidney Transplant Outcomes"],"prefix":"10.1016","volume":"11","author":[{"given":"Seo Yeon","family":"Yoon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"El Bouzaidi Tiali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Wing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Davalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukhdeep","family":"Jatana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Slapcoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy","family":"Nitulescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Rahme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meranda","family":"Nakhla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne N.","family":"Morin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giada","family":"Sebastiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Sapir-Pichhadze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ekir.2026.106477_bib1","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1056\/NEJM199912023412303","article-title":"Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant","volume":"341","author":"Wolfe","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ekir.2026.106477_bib2","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1111\/ajt.16463","article-title":"Long-term kidney transplant graft survival-Making progress when most needed","volume":"21","author":"Poggio","year":"2021","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ekir.2026.106477_bib3","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.mehy.2013.10.030","article-title":"Non-alcoholic fatty liver disease; a part of the metabolic syndrome in the renal transplant recipient and possible cause of an allograft dysfunction","volume":"82","author":"Mikolasevic","year":"2014","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.ekir.2026.106477_bib4","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1056\/NEJMra2014530","article-title":"Long-term survival after kidney transplantation","volume":"385","author":"Hariharan","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ekir.2026.106477_bib5","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.2215\/CJN.0000000744","article-title":"The cardiovascular-kidney-metabolic health framework: implications for nephrology","volume":"20","author":"Rangaswami","year":"2025","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2026.106477_bib6","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/hepr.12642","article-title":"Metabolic syndrome and non-alcoholic fatty liver disease after liver or kidney transplantation","volume":"46","author":"Mikolasevic","year":"2016","journal-title":"Hepatol Res"},{"key":"10.1016\/j.ekir.2026.106477_bib7","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/tri.12805","article-title":"Effects of metabolic syndrome on kidney transplantation outcomes: a systematic review and meta-analysis","volume":"29","author":"Pedrollo","year":"2016","journal-title":"Transpl Int"},{"key":"10.1016\/j.ekir.2026.106477_bib8","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/TP.0b013e31820813ac","article-title":"Metabolic syndrome as a predictor for new-onset diabetes after transplantation--to use or abuse?","volume":"91","author":"Sharif","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.ekir.2026.106477_bib9","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1097\/TP.0b013e31818ffec0","article-title":"Late steroid withdrawal and cardiovascular events in kidney transplant recipients","volume":"86","author":"Arnol","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.ekir.2026.106477_bib10","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1136\/gutjnl-2023-330595","article-title":"MASLD: a systemic metabolic disorder with cardiovascular and malignant complications","volume":"73","author":"Targher","year":"2024","journal-title":"Gut"},{"key":"10.1016\/j.ekir.2026.106477_bib11","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.ekir.2026.106477_bib12","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","article-title":"EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"81","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.ekir.2026.106477_bib13","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.ekir.2026.106477_bib14","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.ekir.2026.106477_bib15","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.cgh.2023.09.018","article-title":"Longitudinal outcomes associated with metabolic dysfunction-associated steatotic liver disease: a meta-analysis of 129 studies","volume":"22","author":"Chan","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.ekir.2026.106477_bib16","doi-asserted-by":"crossref","first-page":"4718","DOI":"10.1038\/s41598-018-23014-0","article-title":"Nonalcoholic fatty liver disease accelerates kidney function decline in patients with chronic kidney disease: a cohort study","volume":"8","author":"Jang","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.ekir.2026.106477_bib17","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jhep.2016.09.022","article-title":"Bi-directional analysis between fatty liver and cardiovascular disease risk factors","volume":"66","author":"Ma","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.ekir.2026.106477_bib18","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/TP.0000000000002480","article-title":"Nonalcoholic fatty liver disease: basic pathogenetic mechanisms in the progression from NAFLD to NASH","volume":"103","author":"Pierantonelli","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.ekir.2026.106477_bib19","article-title":"Metabolic associated steatotic liver disease in renal transplant recipients: a retrospective cohort study","author":"Secondulfo","year":"2025","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.ekir.2026.106477_bib20","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ekir.2026.106477_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128774","article-title":"Prognostic value of non-invasive fibrosis and steatosis tools, hepatic venous pressure gradient (HVPG) and histology in nonalcoholic steatohepatitis","volume":"10","author":"Sebastiani","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ekir.2026.106477_bib22","doi-asserted-by":"crossref","first-page":"6053","DOI":"10.3748\/wjg.v25.i40.6053","article-title":"Ultrasound-based techniques for the diagnosis of liver steatosis","volume":"25","author":"Ferraioli","year":"2019","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ekir.2026.106477_bib23","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New creatinine- and cystatin C-based equations to estimate GFR without race","volume":"385","author":"Inker","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ekir.2026.106477_bib24","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1053\/j.ajkd.2022.03.014","article-title":"Performance of the 2021 race-free CKD-EPI creatinine- and cystatin C\u2013based estimated GFR equations among kidney transplant recipients","volume":"80","author":"Hundemer","year":"2022","journal-title":"Am J Kidney Dis"},{"issue":"Suppl 1","key":"10.1016\/j.ekir.2026.106477_bib25","first-page":"S11","article-title":"Standards of medical care in diabetes\u20142011","volume":"34","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ekir.2026.106477_bib26","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.transproceed.2014.02.017","article-title":"Nonalcoholic Fatty liver disease in renal transplant recipients proven by transient elastography","volume":"46","author":"Mikolasevic","year":"2014","journal-title":"Transplant Proc"},{"key":"10.1016\/j.ekir.2026.106477_bib27","first-page":"14","article-title":"Prevalence of metabolic dysfunction-associated fatty liver disease in kidney transplant recipients: a cross-sectional study using FibroScan","volume":"4","author":"Yesil","year":"2023","journal-title":"Hepatol Forum"},{"key":"10.1016\/j.ekir.2026.106477_bib28","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1053\/gast.2002.35354","article-title":"The utility of radiological imaging in nonalcoholic fatty liver disease","volume":"123","author":"Saadeh","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ekir.2026.106477_bib29","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12876-019-0961-9","article-title":"Diagnostic accuracy of controlled attenuation parameter (CAP) as a non-invasive test for steatosis in suspected non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"19","author":"Pu","year":"2019","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.ekir.2026.106477_bib30","first-page":"7","article-title":"Diagnostic accuracy of ultrasonography for the detection of hepatic steatosis: an updated meta-analysis of observational studies","volume":"1","author":"Stefano","year":"2021","journal-title":"Metab Target Organ Damage"},{"key":"10.1016\/j.ekir.2026.106477_bib31","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/j.gastro.2018.12.036","article-title":"Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease","volume":"156","author":"Castera","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ekir.2026.106477_bib32","doi-asserted-by":"crossref","first-page":"e246","DOI":"10.1016\/j.jhep.2024.02.001","article-title":"Systemic metabolic Abnormalities: key drivers of complications and mortality in MASLD","volume":"80","author":"Fan","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.ekir.2026.106477_bib33","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12916-022-02716-3","article-title":"Lean or diabetic subtypes predict increased all-cause and disease-specific mortality in metabolic-associated fatty liver disease","volume":"21","author":"Chung","year":"2023","journal-title":"BMC Med"},{"key":"10.1016\/j.ekir.2026.106477_bib34","doi-asserted-by":"crossref","first-page":"433","DOI":"10.5009\/gnl210167","article-title":"Innovative Target Exploration of NAFLD (ITEN) Consortium. Metabolic dysfunction-associated fatty liver disease predicts long-term mortality and cardiovascular disease","volume":"16","author":"Moon","year":"2022","journal-title":"Gut Liver"},{"key":"10.1016\/j.ekir.2026.106477_bib35","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/hep.29085","article-title":"Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis","volume":"65","author":"Dulai","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.ekir.2026.106477_bib36","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1056\/NEJMoa2029349","article-title":"Prospective study of outcomes in adults with nonalcoholic fatty liver disease","volume":"385","author":"Sanyal","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ekir.2026.106477_bib37","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1053\/j.gastro.2020.01.043","article-title":"Association between fibrosis stage and outcomes of patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"158","author":"Taylor","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ekir.2026.106477_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001680","article-title":"Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis","volume":"11","author":"Musso","year":"2014","journal-title":"PLOS Med"},{"key":"10.1016\/j.ekir.2026.106477_bib39","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.3390\/jcm10081717","article-title":"Non-alcoholic fatty liver disease is associated with kidney glomerular hyperfiltration in adults with metabolic syndrome","volume":"10","author":"Abbate","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.ekir.2026.106477_bib40","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3810","article-title":"MAFLD and glomerular hyperfiltration in subjects with normoglycemia, prediabetes and type 2 diabetes: a cross-sectional population study","volume":"40","author":"Abbate","year":"2024","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.ekir.2026.106477_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2023.100727","article-title":"Cystatin C as a GFR estimation marker in acute and chronic illness: a systematic review","volume":"5","author":"Adingwupu","year":"2023","journal-title":"Kidney Med"},{"key":"10.1016\/j.ekir.2026.106477_bib42","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1093\/ndt\/gfac327","article-title":"A single centre in-depth analysis of death with a functioning kidney graft and reasons for overall graft failure","volume":"38","author":"Mayrdorfer","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2026.106477_bib43","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1600-6143.2011.03840.x","article-title":"Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence","volume":"12","author":"Sellares","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ekir.2026.106477_bib44","doi-asserted-by":"crossref","first-page":"W320","DOI":"10.2214\/AJR.07.2123","article-title":"Interobserver and intraobserver variability in the sonographic assessment of fatty liver","volume":"189","author":"Strauss","year":"2007","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.ekir.2026.106477_bib45","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/ajum.12381","article-title":"Hepatic steatosis: qualitative and quantitative sonographic assessment in comparison to histology","volume":"27","author":"Tan","year":"2024","journal-title":"Australas J Ultrasound Med"},{"key":"10.1016\/j.ekir.2026.106477_bib46","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.kint.2025.09.023","article-title":"New potential therapeutic targets of metabolic disorder-associated kidney disease and diabetic kidney disease","volume":"109","author":"Li","year":"2026","journal-title":"Kidney Int"}],"container-title":["Kidney International Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024926027099?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024926027099?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T09:24:15Z","timestamp":1780478655000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468024926027099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2468024926027099"],"URL":"https:\/\/doi.org\/10.1016\/j.ekir.2026.106477","relation":{},"ISSN":["2468-0249"],"issn-type":[{"value":"2468-0249","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic Dysfunction-Associated Steatotic Liver Disease and Kidney Transplant Outcomes","name":"articletitle","label":"Article Title"},{"value":"Kidney International Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ekir.2026.106477","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of the International Society of Nephrology.","name":"copyright","label":"Copyright"}],"article-number":"106477"}}